{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:29:35Z","timestamp":1769074175101,"version":"3.49.0"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aktuelle Urol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n            Introduction\/background: Although a full bilateral template RPLND\n      is thought to be the standard of care for the management of postchemotherapy retroperitoneal\n      residual masses for nonseminomatous germ cell tumors (NSGCT), in the past decade modified\n      templates have become increasingly popular. In this study, we aimed to present our oncological\n      and perioperative outcomes of consecutive seventeen NSGCT patients who underwent a modified\n      template unilateral PC-RPLND for retroperitoneal residual disease.<\/jats:p><jats:p>\n            Materials and Methods: We retrospectively evaluated the medical\n      records of 17 consecutive NSGCT patients who underwent modified template unilateral PC-RPLND\n      in our university hospital between 2017 and 2020. All patients had normal serum tumour markers\n      with residual disease in the retroperitoneum. Surgical characteristics including the size of\n      the retroperitoneal residual mass, residual tumor pathology, removed lymph nodes, positive\n      percentage of removed lymph nodes, accompanying operations, complications, mean operation time\n      and hospital stay, and long-term results including survival and antegrade ejaculation were\n      evaluated.<\/jats:p><jats:p>\n            Results: Eleven patients underwent left and six right-sided\n      surgery. Median residual lymph node diameter was 41mm. Median hospitalisation time was 3.5\n      days. Median follow-up time was 10.5 months. Necrosis\/fibrosis was seen in 6 patients, and\n      teratoma in 11 patients. No viable tumour was seen. No patients died in the follow-up period.\n      None of the patients relapsed during follow-up. Ten\/seventeen patients had antegrade\n      ejaculation.<\/jats:p><jats:p>\n            Conclusions: Modified template unilateral PC-RPLND leads to very\n      good oncological outcomes with decreased perioperative morbidity as well as better antegrade\n      ejaculation rates. Low volume retroperitoneal disease seems to fit this procedure best.<\/jats:p>","DOI":"10.1055\/a-1469-6892","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:02:46Z","timestamp":1635984166000},"page":"325-330","source":"Crossref","is-referenced-by-count":1,"title":["Post-chemotherapy modified template retroperitoneal lymph node dissection in patients with nonseminomatous germ cell tumours"],"prefix":"10.1055","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2597-5026","authenticated-orcid":false,"given":"Murat","family":"Zor","sequence":"additional","affiliation":[{"name":"Department of Urology, Gulhane Research and Training Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sercan","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Urology, Gulhane Research and Training Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahadir","family":"Topuz","sequence":"additional","affiliation":[{"name":"Department of Urology, Gulhane Research and Training Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Engin","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Urology, Gulhane Research and Training Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Yalcin","sequence":"additional","affiliation":[{"name":"Department of Urology, Gulhane Research and Training Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-4989","authenticated-orcid":false,"given":"Adem Emrah","family":"Coguplugil","sequence":"additional","affiliation":[{"name":"Department of Urology, Gulhane Research and Training Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Emin","family":"Ince","sequence":"additional","affiliation":[{"name":"Department of Urology, Gulhane Research and Training Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Gurdal","sequence":"additional","affiliation":[{"name":"Department of Urology, Gulhane Research and Training Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,11,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ajur.2020.05.007","article-title":"Surgical treatment of metastatic germ cell cancer","volume":"8","author":"A Hiester","year":"2021","journal-title":"Asian J Urol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and\n          follow-up","volume":"29","author":"F Honecker","year":"2018","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/cncr.22898","article-title":"Is full bilateral retroperitoneal lymph node dissection always necessary for\n          postchemotherapy residual tumor?","volume":"110","author":"SD Beck","year":"2007","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11934-013-0366-1","article-title":"Critical evaluation of modified templates and current trends in retroperitoneal\n          lymph node dissection","volume":"14","author":"S Pearce","year":"2013","journal-title":"Curr Urol Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"P Albers","year":"2015","journal-title":"Eur Urol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular\n          cancer: radical or modified template resection","volume":"55","author":"A Heidenreich","year":"2009","journal-title":"Eur Urol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/bju.13844","article-title":"Modified retroperitoneal lymph node dissection for post-chemotherapy residual\n          tumour: a long-term update","volume":"120","author":"JS Cho","year":"2017","journal-title":"BJU Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International germ cell consensus classification: a prognostic factor-based\n          staging system for metastatic germ cell cancers","volume":"15","author":"International Germ Cell Cancer Collaborative Group","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.urolonc.2018.09.009","article-title":"Current Controversies on the Role of Retroperitoneal Lymphadenectomy for\n          Testicular Cancer","volume":"37","author":"R Mano","year":"2019","journal-title":"Urol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1200\/JCO.2003.03.184","article-title":"Postchemotherapy retroperitoneal surgery remains necessary in patients with\n          nonseminomatous testicular cancer and minimal residual tumor masses","volume":"21","author":"J Oldenburg","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1464-410X.2006.06167.x","article-title":"Distribution of nodal metastases after chemotherapy in nonseminomatous testis\n          cancer: a possible indication for limited dissection","volume":"97","author":"Y Ehrlich","year":"2006","journal-title":"BJU Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e27343","DOI":"10.5812\/numonthly.27343","article-title":"Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With\n          Nonseminomatous Testicular Cancer: A Single Center Experiences","volume":"7","author":"M Nowroozi","year":"2015","journal-title":"Nephrourol Mon"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.juro.2010.06.146","article-title":"Ejaculatory status and fertility rates after primary retroperitoneal lymph node\n          dissection","volume":"184","author":"SD Beck","year":"2010","journal-title":"J Urol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.21037\/tau-2019-suc-18","article-title":"Retroperitoneal lymph node dissection for germ cell tumour","volume":"9","author":"V Tran","year":"2020","journal-title":"Transl Androl Urol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11912-019-0758-6","article-title":"Management of Residual Mass in Germ Cell Tumors After Chemotherapy","volume":"21","author":"C Albany","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2011.10.045","article-title":"Residual tumor size and IGCCCG risk classification predict additional vascular\n          procedures in patients with germ cell tumors and residual tumor resection: a multicenter\n          analysis of the German Testicular Cancer Study Group","volume":"61","author":"C Winter","year":"2012","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"389.e15","DOI":"10.1016\/j.urolonc.2014.07.013","article-title":"Contemporary trends in postchemotherapy retroperitoneal lymph node dissection:\n          additional procedures and perioperative complications","volume":"33","author":"C Cary","year":"2015","journal-title":"Urol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.urology.2016.01.010","article-title":"Characterizing the morbidity of postchemotherapy retroperitoneal lymph node\n          dissection for testis cancer in a national cohort of privately insured patients","volume":"91","author":"LC Macleod","year":"2016","journal-title":"Urology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1245\/s10434-012-2284-8","article-title":"Adjuvant surgery in testicular cancer patients undergoing postchemotherapy\n          retroperitoneal lymph node dissection","volume":"19","author":"H Djaladat","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1080\/0284186X.2018.1449249","article-title":"Limited post-chemotherapy retroperitoneal resection of residual tumour in\n          non-seminomatous testicular cancer: complications, outcome and quality of life","volume":"57","author":"AH Schmidt","year":"2018","journal-title":"Acta Oncol"},{"key":"ref21","first-page":"368","article-title":"Early and late complications of retroperitoneal lymphadenectomy in testis\n          cancer","volume":"34","author":"MA Jewett","year":"1991","journal-title":"Can J Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/a-1176-9796","article-title":"Retroperitoneal lymph node dissection in testicular germ cell tumours:\n          indications, complications and special cases","volume":"51","author":"P John","year":"2020","journal-title":"Aktuelle Urol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12957-020-02032-1","article-title":"Major complications of post-chemotherapy retroperitoneal lymph node dissection in\n          a contemporary cohort of patients with testicular cancer and a review of the\n          literature","volume":"18","author":"CG Ruf","year":"2020","journal-title":"World J Surg Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1477-7819-8-97","article-title":"Retroperitoneal lymph node dissection for residual masses after chemotherapy in\n          nonseminomatous germ cell testicular tumor","volume":"8","author":"MA Luz","year":"2010","journal-title":"World J Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.eururo.2012.08.014","article-title":"Contemporary management of postchemotherapy testis cancer","volume":"62","author":"S Daneshmand","year":"2012","journal-title":"Eur Urol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1464-410X.2007.06740.x","article-title":"Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection\n          in men with intermediate-and poor-risk nonseminomatous germ cell tumour","volume":"99","author":"B Shayegan","year":"2007","journal-title":"BJU Int"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1756287211418721","article-title":"Management of residual mass in nonseminomatous germ cell tumors following\n          chemotherapy","volume":"3","author":"S Daneshmand","year":"2011","journal-title":"Ther Adv Urol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ucl.2019.04.004","article-title":"Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell\n          Tumor","volume":"46","author":"S Ghodoussipour","year":"2019","journal-title":"Urol Clin North Am"}],"container-title":["Aktuelle Urologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1469-6892.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:52:35Z","timestamp":1730818355000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1469-6892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":28,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2022,8,3]]},"published-print":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1469-6892","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0001-7868","1438-8820"],"issn-type":[{"value":"0001-7868","type":"print"},{"value":"1438-8820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,3]]}}}